In the run-up to our panel discussion “Science, Strategy & Scale – Shaping Europe’s Pharma and Healthcare Transformation under Global Pressure”, Handelsblatt spoke with Chantal Friebertsh?user (Moderna).
The conversation focuses on key strategic perspectives from Moderna’s European operations and explores how regulatory change, geopolitical uncertainty and innovation in vaccines and mRNA therapies are reshaping Europe’s healthcare landscape.
The interview provides initial impulses for the panel debate and offers insights into how science, strategy and scale must align to strengthen Europe’s pharmaceutical and healthcare ecosystem under global pressure.